Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3029 of 6351
-
Scientists hunt for genes behind rare bone tumor diseases
Knowledge-focused Recruiting nowBackground: Ollier disease (OD) and Maffucci syndrome (MS) are rare disorders that increase the risk of cancers in cartilage tissue. These tumors can lead to severe skeletal deformities beginning in childhood. People with OD or MS are also at an increased risk of blood vessel di…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough leukemia? early trial of ABBV-453 begins
Disease control OngoingChronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries. The purpose of this study is to assess how well ABBV-453 works adult participants with relapsed/refractory (R/R) untreated CLL/small lymphocytic lymphoma (SLL). Adverse events, pharmacokinetics, …
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Eating your way to a sharper mind: new study tests diet against dementia
Prevention Recruiting nowThis study intends to evaluate the feasibility and the effectiveness of an innovative and integrated nutrition-based intervention addressing key modifiable risk factors for dementia while meeting participants' preferences for nutrition-related sessions. The intervention will incl…
Sponsor: Instituto de Saude Publica da Universidade do Porto • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Brain zapping after magic mushrooms may lock in Life-Changing insights
Knowledge-focused Recruiting nowThis study will examine whether combining a single dose of psilocybin with non-invasive transcutaneous auricular vagus nerve stimulation (taVNS), a potential inducer of neuroplasticity and enhanced memory formation, will enhance the long-term beneficial behavioral effects of psil…
Phase 1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
AI takes on rare brain tumors: a new hope for personalized care
Knowledge-focused Recruiting nowThis study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors. The main objective of the study is to sta…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Virtual physical therapy aims to ease back pain for rural patients
Symptom relief Recruiting nowPhysical therapy is the first line of treatment for patients with low back pain (LBP) and has been shown to be a cost-effective method for improving pain and disability in patients with chronic LBP; however, despite this effectiveness, only 7-13% of patients go on to receive phys…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Texts and peers aim to keep cancer survivors moving
Symptom relief Recruiting nowThe aim of this project is to help increase physical activity maintenance in cancer survivors.
Sponsor: University of Tennessee • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Home workouts tested as therapy for rare lung disease
Symptom relief Recruiting nowPulmonary arterial hypertension (PAH) is a rare and severe disease characterized by elevation of pulmonary artery pressure (PAP) and increased pulmonary vascular resistance (PVR) due to the narrowing of small pulmonary arteries. The European Society of Cardiology (ESC) and the Eu…
Sponsor: Tampere Heart Hospital • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
New pill shows promise for keeping people with narcolepsy awake longer
Symptom relief Recruiting nowThe purpose of this study is to continue to measure the safety, tolerability, and durability of treatment effect in subjects with Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), or Idiopathic Hypersomnia (IH) when taking ALKS 2680 tablets.
Phase 2/3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a smartphone app boost sexual health after a stem cell transplant?
Symptom relief Recruiting nowThis research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Virtual workouts could boost heart health in women
Symptom relief Recruiting nowThis study will compare the effects of two different types of training on exercise capacity in women with coronary heart disease (CHD). Participants will be randomized into either the virtual high-intensity interval training (HIIT) or the virtual moderate-to-vigorous intensity co…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Can a daily supplement shed pounds without diet or exercise?
Disease control OngoingThe goal of this clinical trial is to learn if motus, a natural supplement can support healthy weight loss and fat loss in a real world setting without caloric restrictions or exercise requirements. The main questions it aims to answer are: Can a daily dose of motus result in s…
Sponsor: Prostasis, LLC, dba Tonum Health • Aim: Disease control
Last updated Jun 26, 2026 15:08 UTC
-
Oxygen gel and light may boost gum disease treatment
Disease control Recruiting nowPeriodontitis is a serious gum disease that can damage the tissues supporting the teeth. The standard treatment is scaling and root planing of the teeth and roots. However, in some patients, this treatment alone may not fully control inflammation and harmful bacteria. This study…
Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Nerve block shows promise for Alzheimer's symptoms in small trial
Symptom relief CompletedThe goal of this clinical trial is to learn if ultrasound-guided stellate ganglion block (SGB), added to standard drug treatment, can improve thinking and memory in people with Alzheimer's disease. It will also learn about the safety of SGB. The main questions this study aims to…
Sponsor: Taizhou Second People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Chest nerve block may help heart surgery patients breathe easier
Symptom relief Recruiting nowIn adult patients undergoing cardiac surgery, does adding an sPIP block to standard care compared to standard care alone result in a smaller decrease in PFTs?
Sponsor: Shai Fein • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New program tackles stress to boost exercise in overweight black teens
Disease control By invitation onlyChronic stressors have wide-reaching harmful effects on the physical, social, and psychological well-being of many African American (AA) families. These stressors place some AA adolescents, who already experience low rates of physical activity (PA) and high rates of obesity, at e…
Sponsor: University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can dancing more often slow Parkinson's? new study tests the idea
Disease control Recruiting nowVeterans with mid to later stage Parkinson's disease (PD) may not be able to work out as hard as they need to, to prevent brain cell loss. Maybe they could work out longer and more frequently to make up for this during their good times and good weeks and then rest during the bad …
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a home visit program get kidney patients off the sidelines?
Symptom relief Recruiting nowThe purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Beetroot powder may help lower blood pressure in men
Disease control Recruiting nowObjective: to evaluate the effectiveness of using a food product, dry finely dispersed beetroot powder in a dose of 20 g, containing 800 mg of nitrate (NO3-), in relation to the regulation of blood pressure in men with hypertension who reached the target blood pressure level whil…
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New cancer drug IPH4502 enters first human tests
Disease control OngoingThis is a first-in-human, open-label, multicenter, Phase 1 study to evaluate the safety, tolerability and preliminary efficacy of IPH4502 and to determine the recommended Phase 2 dose (RP2D) in advanced solid tumors that are known to express Nectin-4
Phase 1 • Sponsor: Innate Pharma • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC